Safety Profile - Entresto
ENTRESTO ® demonstrated comparable safety and tolerability vs Enalapril
- Twitter Linkedin Facebook Pinterest Google plus
Indications
Cosentyx is approved in 7 indications 1 :
Adult plaque psoriasisCosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy....
Twitter Linkedin Facebook Pinterest Google plusMechanism of action
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Cosentyx PsA
Dose recommendation - Jakavi
Mechanism of Action - Jakavi
Uncontrolled JAK/STAT signalling is characteristic of both polycythaemia vera (PV) 1–5 a nd for myelofibrosis (MF). 6
JAKs are tyrosine kinases that transmit signals from cytokine or growth factor receptors to the cell...Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Jakavi
Mechanism of Action - Kisqali
Ribociclib is a selective inhibitor of cyclin-dependent kinase (CDK) 4 and 6, resulting in 50% inhibition (IC50) values of 0.01 (4.3 ng/ml) and 0.039 μM (16.9 ng/ml) in biochemical assays, respectively. These kinases are activated upon binding to D-...
Twitter Linkedin Facebook Pinterest Google plusTraining/Video - Kisqali legacy
Patient Resources - Scemblix
×